TSCAN THERAPEUTICS, INC. Operating Lease, Liability, Current
TSCAN THERAPEUTICS, INC. (TCRX) had Operating Lease, Liability, Current of $7.72 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $7.72M.
- 2026-03-31: Operating Lease, Liability, Current $7.44M.
- 2025-12-31: Operating Lease, Liability, Current $7.17M.
- 2025-09-30: Operating Lease, Liability, Current $6.90M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $7.72M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $7.44M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $7.17M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $6.90M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $6.29M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $4.97M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $4.57M 10-K · filed 2026-03-04 |
| 2024-09-30 | $3.90M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.61M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $3.34M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $3.25M 10-K · filed 2025-03-05 |
| 2023-09-30 | $4.38M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.21M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.84M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.68M 10-K · filed 2024-03-06 |
| 2022-09-30 | $1.79M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.75M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.70M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.65M 10-K · filed 2023-03-08 |
| 2021-09-30 | $1.62M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.57M 10-Q · filed 2021-08-19 |
| 2020-12-31 | $1.42M 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |